An interventional study of oxytocin treatment and placebo treatment in Healthy, sponsored by University of Electronic Science and Technology of China. Completed at 1 site in China. Open to participants aged 19 Years to 28 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-03-06.
Sponsored by University of Electronic Science and Technology of China · Not applicable, Interventional, and Basic science
To investigate whether intranasal oxytocin (40 IU) treatment can influence the tolerance of infidelity in males and females.
In a double-blind, between-subject, placebo controlled design, investigators plan to investigate the effect of oxytocin treatment on the tolerance of infidelity. Male and female subjects would firstly see a neutral face of the opposite sex presented with a sentence descried their fidelity or infidelity behavior (sexual or emotional) in a relationship. Next the participant will rate the attractiveness, likability and trustworthiness of each individual, and whether they would like to have a short/long relationship with him/her. After that there will be some implicit attitude tasks to test their implicit attitude towards potential partners exhibiting previous fidelity or and infidelity.
University of Electronic Science and Technology of China is the lead sponsor of 109 studies on the registry; 35 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
male subjects with oxytocin treatment
Drug: oxytocin treatment
female subjects with oxytocin treatment
Drug: oxytocin treatment
male subjects with placebo treatment
Drug: placebo treatment
female subjects with placebo treatment
Drug: placebo treatment
intranasal administration of oxytocin (40 IU)
intranasal administration of placebo (40 IU)
attitude towards fidelity and infidelity of potential mate.
attitude is measured by the rating scores for likability, attractiveness and trustworthiness
Time frame: 1 hour
This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Electronic Science and Technology of China